Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 12, 2022

BUY
$12.27 - $18.49 $61 - $92
5 New
5 $1,000
Q3 2021

Oct 06, 2021

SELL
$13.38 - $18.8 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$17.08 - $29.6 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

SELL
$5.86 - $27.73 $2,930 - $13,865
-500 Closed
0 $0
Q4 2020

Jan 25, 2021

BUY
$2.65 - $7.61 $1,325 - $3,805
500 New
500 $3,000
Q4 2017

Jan 24, 2018

SELL
$21.47 - $27.8 $257 - $333
-12 Closed
0 $0
Q2 2017

Jun 03, 2019

BUY
N/A
12
12 $0

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $253M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.